ConductScience.org, home

Paper89832

Three-dimensional structure of immunoglobulins.

Amzel LM and 1 other. Annu Rev Biochem, 1979. Cited by 539 papers, by iCite.

Cite this record

ConductScience Library. Three-dimensional structure of immunoglobulins. Papers, record 89832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/89832

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Three-dimensional structure of immunoglobulins.
PubMed
Journal
Annu Rev Biochem
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
539
iCite
Relative citation ratio, by iCite
10.4
iCite
Revised in PubMed
2024-01-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amzel LML M
2Poljak RJR J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunoglobulinsMajor topic
Amino Acid Sequence
Animals
Carbohydrates
Epitopes
Humans
Hydrogen Bonding
Immunoglobulin Fab Fragments
Immunoglobulin Fc Fragments
Immunoglobulin G
Macromolecular Substances
Models, Molecular
Protein Conformation
X-Ray Diffraction

Source PubMed

Download CSV of topics

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 539 citations.

PMIDTitleJournalYearIn PapersSource
41301426Fab N-Glycosylation in IgG: Implications in Physiological and Pathological Immune Regulation.Biomolecules2025https://conductscience.org/library/papers/41301426PubMed
40764467Tracking reduction-induced molecular changes in pathological free light chains by SV-AUC.Eur Biophys J2025https://conductscience.org/library/papers/40764467PubMed
40237455Public antibodies: convergent signatures in human humoral immunity against pathogens.mBio2025https://conductscience.org/library/papers/40237455PubMed
40180946Protein sequence modelling with Bayesian flow networks.Nat Commun2025https://conductscience.org/library/papers/40180946PubMed
39459230A Simple Analysis of the Second (Extra) Disulfide Bridge of VHHs.Molecules2024https://conductscience.org/library/papers/39459230PubMed
38015984abYpap: improvements to the prediction of antibody VH/VL packing using gradient boosted regression.Protein Eng Des Sel2023https://conductscience.org/library/papers/38015984PubMed
37784026Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.BMC Cancer2023https://conductscience.org/library/papers/37784026PubMed
37602255FcRN receptor antagonists in the management of myasthenia gravis.Front Neurol2023https://conductscience.org/library/papers/37602255PubMed
37041231Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants.Commun Biol2023https://conductscience.org/library/papers/37041231PubMed
35547980Immunoactivity of self-assembled antibodies investigated by atomic force microscopy.RSC Adv2018https://conductscience.org/library/papers/35547980PubMed
35464485Sialylation as an Important Regulator of Antibody Function.Front Immunol2022https://conductscience.org/library/papers/35464485PubMed
34226529Current insights into the expression and functions of tumor-derived immunoglobulins.Cell Death Discov2021https://conductscience.org/library/papers/34226529PubMed
3395711950 Years of structural immunology.J Biol Chem2021https://conductscience.org/library/papers/33957119PubMed
33200817Cysteine in cell culture media induces acidic IgG1 species by disrupting the disulfide bond network.Biotechnol Bioeng2021https://conductscience.org/library/papers/33200817PubMed
31841553Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans.PLoS Pathog2019https://conductscience.org/library/papers/31841553PubMed
31816964Antibody Structure and Function: The Basis for Engineering Therapeutics.Antibodies (Basel)2019https://conductscience.org/library/papers/31816964PubMed
30277476Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.J Clin Invest2018https://conductscience.org/library/papers/30277476PubMed
29469657Direct mass spectrometric characterization of disulfide linkages.MAbs2018https://conductscience.org/library/papers/29469657PubMed
28932819IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow.Bioeng Transl Med2017https://conductscience.org/library/papers/28932819PubMed
28747530Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28747530PubMed

See all 119 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/89832

GET https://conductscience.org/api/papers/v1/89832/cited_by?page=2